SARS-CoV-2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens.

ABSTRACT:

Purpose

The purpose of this study was to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) in urine and blood specimens, and anal and oropharyngeal swabs from patients with confirmed SARS-CoV-2 infection, and correlated positive results with clinical findings.

Methods

Patients with confirmed SARS-CoV-2 infections were included in this study. Patients' demographic and clinical data were recorded. Quantitative real-time polymerase chain reaction was used to detect SARS-CoV-2 RNA in urine and blood specimens, and anal and oropharyngeal swabs. The study is registered at ClinicalTrials.gov (No. NCT04279782, 19 February, 2020).

Results

SARS-CoV-2 RNA was present in all four specimen types, though not all specimen types were positive

SUBMITTER: Peng L 

PROVIDER: S-EPMC7264521 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature